Udo Kontny

16PUBLICATIONS
124CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Innate immunityMolecular targetsPredictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 18, 2026
ADA2 genotype and enzyme activity may predict vasculitic or hematologic DADA2 phenotype.

|May 27, 2026
Natural Killer (NK) Cells in Tumor Immunity: Limitations and Therapeutic Potential with a Focus on Nasopharyngeal Carcinoma and Comparison with T-Cell-Based Therapies.

|Dec 30, 2025
Inhibition of PD-L1/PD-1 Checkpoint Increases NK Cell-Mediated Killing of Melanoma Cells in the Presence of Interferon-Beta.

Anna Makowska, Lian Shen, Christina Nothbaum

|Jun 03, 2025
Colorectal Carcinoma in Childhood and Adolescence: Microsatellite Instability Correlates With a Favorable Prognosis.

Hannah Wild, Alexandra Liebmann, Lucas Maennel

|May 30, 2025
One-Two Punch: Combining Chemotherapy and Immunotherapy to Decrease Radiation Dose and Related Toxicity in Children and Adolescents with Nasopharyngeal Carcinoma.

Hetal Dholaria, Vera Tsetlina, Shae K Simpson

|Oct 03, 2024
Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas.

Anja Fischer, Thomas K Albert, Natalia Moreno

Pageof 3

Frequent Collaborators

4 joint publications

Birgit Burkhardt

3 joint publications

Udo Kontny

3 joint publications

Wolfram Klapper

3 joint publications

Wilhelm Wössmann